ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs MXN
16.9059
0.12%
Brent Oil
82.845
-0.02%
Bitcoin
62,461.38
0.20%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Exicure Inc (XCUR)

  7. Exicure Inc (XCUR) Noticias

XCUR

Exicure (XCUR)

Exicure Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XCUR
FechaHoraFuenteTítuloSímboloCompañía
22/04/202415:01Business WireExicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-KNASDAQ:XCURExicure Inc
06/03/202411:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
04/03/202416:37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:XCURExicure Inc
05/02/202415:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
05/02/202415:01Business WireExicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of HepatitisNASDAQ:XCURExicure Inc
28/11/202315:01Business WireExicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-QNASDAQ:XCURExicure Inc
14/11/202315:28Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:XCURExicure Inc
29/09/202316:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XCURExicure Inc
23/08/202308:48Business WireExicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of DirectorsNASDAQ:XCURExicure Inc
11/08/202315:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XCURExicure Inc
11/08/202315:01Business WireExicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:XCURExicure Inc
14/07/202315:01Business WireExicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:XCURExicure Inc
28/06/202315:22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XCURExicure Inc
27/06/202317:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XCURExicure Inc
27/06/202316:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:XCURExicure Inc
14/06/202315:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XCURExicure Inc
26/05/202315:01Business WireExicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic AlternativesNASDAQ:XCURExicure Inc
15/05/202316:17Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:XCURExicure Inc
04/05/202315:01Business WireExicure, Inc. Announces Investment in Korean SNS Platform CyworldNASDAQ:XCURExicure Inc
01/05/202316:26Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:XCURExicure Inc
27/03/202315:37Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XCURExicure Inc
27/03/202315:01Business WireExicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:XCURExicure Inc
24/02/202316:10Business WireExicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of DirectorsNASDAQ:XCURExicure Inc
14/12/202206:18Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XCURExicure Inc
14/12/202204:00Business WireExicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration AgreementsNASDAQ:XCURExicure Inc
14/11/202215:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XCURExicure Inc
14/11/202215:01Business WireExicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:XCURExicure Inc
10/11/202216:15Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XCURExicure Inc
26/09/202215:01Business WireExicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic AlternativesNASDAQ:XCURExicure Inc
01/09/202206:00Business WireExicure Announces Presentation at Chardan’s 6th Annual Genetic Medicines ConferenceNASDAQ:XCURExicure Inc
 Showing the most relevant articles for your search:NASDAQ:XCUR

Su Consulta Reciente

NYSE
DIS
Walt Disney
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
NYSE
MCD
McDonalds
NYSE
CVX
Chevron
COIN
ETHUSD
Ethereum
NYSE
NKE
Nike
NASDAQ
AMZN
Amazon.com
COIN
SOLUSD
Solana
FX
EURMXN
Euro vs MXN
NASDAQ
MSFT
Microsoft
USOTC
BNPQY
BNP Paribas (QX)
NYSE
MRK
Merck
USOTC
DTEGY
Deutsche Telekom (QX)
FX
EURUSD
Euro vs US Dollar
CCOM
OILBRENT
Brent Oil
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados